24.12.2012 Views

Infertility Nursing - Omnia Education

Infertility Nursing - Omnia Education

Infertility Nursing - Omnia Education

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

tHE OMnia cME JOURnal tm | sEPtEMBER 2011<br />

to 15 days after retrieval (as a result of<br />

the hcg if pregnancy occurs). the risk<br />

of severe complications is about 4 to 12<br />

times higher if pregnancy occurs, which<br />

is why sometimes no embryo transfer is<br />

performed to reduce the possibility of<br />

this occurring. 9<br />

Early signs and symptoms of OHss<br />

include abdominal bloating, pelvic pain,<br />

weight gain of 1-2 pounds, nausea and/<br />

or vomiting, decreased urine output, and<br />

shortness of breath. Patients who are<br />

considered at risk need to be educated<br />

on the signs and symptoms as well as<br />

the potential severity of OHss. Patients<br />

should be instructed to notify their nurse<br />

or physician immediately with onset<br />

of any of these signs and symptoms.<br />

Patients at risk should be cautioned to<br />

limit their activities and increase PO<br />

fluids. Physicians, working with patients<br />

at risk for OHss, should consider low<br />

gonadotropin dose initially as well as<br />

frequent monitoring and adjustment<br />

of dosage during cycle if needed.<br />

cancelation of the insemination is<br />

sometimes the best prevention of OHss<br />

as well multiple pregnancies. iVF patients<br />

may benefit from having egg retrieval<br />

and cryopreservation of embryos.<br />

figure 1<br />

Indication for Ovulation Induction or COH<br />

WHO type I- anovulation<br />

(Hypogonadotropic hypogonadism)<br />

WHO type II - (hyperandrogenic-PCOS/<br />

Oligomenorrheic)<br />

unexplained infertility including<br />

Endometriosis I & II (no iUi)<br />

unexplained <strong>Infertility</strong> including<br />

Endometriosis I & II (with iUi)<br />

% Pregnant<br />

(per cycle)<br />

Total % Pregnant<br />

after 4 cycles<br />

29% 67%<br />

18-19% 30-58%<br />

7.7-8% 19%<br />

17.1-18% 33%<br />

Fluker et al. 1994<br />

guzick et al. 1998 &1999<br />

reassuring for patients<br />

no increased risks<br />

Miscarriage Rate: 20-25%, about equal<br />

to the general population and is age<br />

dependent.<br />

Ectopic Pregnancy Rate: 2-5%, equal<br />

to or slightly higher than the general<br />

population.<br />

congenital anomalies: the risk is equal<br />

to the general population. 10<br />

Ovarian cancer: “no convincing<br />

association was found between use of<br />

fertility drugs and risk of ovarian cancer.<br />

Furthermore, no associations were found<br />

between all four groups of fertility drugs<br />

and number of cycles of use, length of<br />

follow-up, or parity.” 11<br />

results of ovulation induction/<br />

controlled ovarian hyperstimulation<br />

with gonadotropins<br />

the results of Oi/cOH presented in<br />

figure 1 are dependant upon many<br />

factors including primary diagnosis,<br />

the woman’s age, quality of sperm, and<br />

quality of pelvic anatomy, as well as<br />

other diagnoses that may be present.<br />

the results presented below are from the<br />

literature. they are listed to provide you<br />

with an overall perspective regarding the<br />

general effectiveness of this therapy.<br />

in a retrospective review of over 450<br />

treatment cycles, Fluker et al., examines<br />

the cumulative pregnancy rates in cOH<br />

cycles in WHO group i & WHO group<br />

ii patients. 12 in another retrospective<br />

analysis of 45 published reports, guzick<br />

et al. suggests that empiric gonadotropin<br />

therapy is an effective therapy for<br />

unexplained infertility, especially when<br />

combined with iUi. 13 guzick then showed<br />

in a large randomized multicenter trial<br />

that FsH combined with iUi yielded<br />

higher cumulative pregnancy rates than<br />

FsH alone. 14 it should be noted that<br />

maternal age was a significant predictor<br />

of conception in all of these studies. 12-14<br />

Each patient should discuss their specific<br />

case with their doctor in order to<br />

determine their prognosis and potential<br />

success rates.<br />

assisted reproductive<br />

technologies (art)<br />

although, cOH/iUi results can be<br />

promising, some patients may choose to<br />

go directly to iVF following failed cc<br />

treatment to optimize their outcome.<br />

this has been demonstrated as a rational<br />

and cost effective approach by Fastt—a<br />

randomized clinical trial comparing two<br />

groups of treatment regimens, one with<br />

a “faster” approach. the first treatment<br />

group has a more traditional approach of<br />

following clomiphene/iUi treatment by<br />

cOH/iUi before moving on to iVF which<br />

is compared to a second more aggressive<br />

approach of clomiphene/iUi followed<br />

by moving directly on to iVF. the main<br />

outcome measure was the time it took to<br />

establish a pregnancy that led to a live<br />

birth and cost-effectiveness. Reindollar et<br />

al. results demonstrated an increased rate<br />

of pregnancy observed in the accelerated<br />

arm compared with the conventional arm. 15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!